Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Intangibles (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Intangibles for 3 consecutive years, with $544.3 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Intangibles changed N/A year-over-year to $544.3 million, compared with a TTM value of $544.3 million through Jun 2025, changed N/A, and an annual FY2024 reading of $595.2 million, down 32.47% over the prior year.
  • Intangibles was $544.3 million for Q2 2025 at BrightSpring Health Services, down from $568.3 million in the prior quarter.
  • Across five years, Intangibles topped out at $881.5 million in Q4 2023 and bottomed at $544.3 million in Q2 2025.
  • Average Intangibles over 3 years is $647.3 million, with a median of $581.8 million recorded in 2024.
  • Peak annual rise in Intangibles hit 32.47% in 2024, while the deepest fall reached 32.47% in 2024.
  • Year by year, Intangibles stood at $881.5 million in 2023, then tumbled by 32.47% to $595.2 million in 2024, then decreased by 8.55% to $544.3 million in 2025.
  • Business Quant data shows Intangibles for BTSG at $544.3 million in Q2 2025, $568.3 million in Q1 2025, and $595.2 million in Q4 2024.